51 min listen
Unavailable
ratings:
Length:
64 minutes
Released:
Feb 13, 2017
Format:
Podcast episode
Description
Our guest is Dr Henry Fisher, policy director at the UK-based drug policy think tank, VolteFace. Henry and the team at VolteFace are hoping to make positive changes to current UK drug policy by getting people outside the drug reform community involved in the debate. Politicians are much more likely to listen to patient groups, economic think tanks or doctors than people in the drug reform community: and this is how VolteFace hope to change the face of drug policy in the UK. For a full summary and show links, go here: https://thethirdwave.co/psychedelia-henry-fisher/
Released:
Feb 13, 2017
Format:
Podcast episode
Titles in the series (100)
Ronan Levy - Regulating Psychedelic Medicine, FDA Approval, and Why We Need More Evidence: In this podcast, Paul F. Austin, founder of Third Wave, speaks with Ronan Levy, Co-founder and Executive Chairman of Field Trip Health. Together, they cover several controversial themes—including the role regulation should play in the psychedelic... by The Psychedelic Podcast